Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
William is a Director, Quality and Risk Management, Global Medical and Safety Governance, supporting the Africa and Developing Countries of Asia at GlaxoSmithKline. In his role, William he is responsible for providing technical support to Country Medical Teams across 53 distinct countries medical affairs, governance, pharmacovigilance, medical information and human subject research, aiming to strengthen and drive simplification in the operating model. At a Global level, he links the local units with the global teams driving organizational alignment and feeding into the development of global medical governance strategies.
He began his career with GSK in 2011 as a Medical Advisor supporting 13 East African countries and worked across a wide range of medical affairs therapeutic areas including anti-infectives, respiratory, allergy, dermatology, cardiovascular, gastroenterology, oncology, neurosciences and vaccines. He also worked as a nominated safety contact, providing pharmacovigilance oversight to the Eastern African countries. In 2014 he became the Country Medical Director, a position he held for two years.
William is a 2017 Oxford University-African Leadership Institute, Archbishop Desmond Tutu Fellow. He holds a First Class Master’s Degree in Pharmaceutical Medicine from Ireland and is a Bachelor of Medicine and Surgery graduate from the University of Nairobi. He is a Top 40 Under 40 Awardee Kenya – 2015. He has co-authored articles on antibiotic resistance, burden of rotavirus gastroenteritis, influenza shedding and use of webinars for medical education. He was involved in the introduction and of pneumonia and rotavirus vaccines across several East Africa countries while overseeing the development of the new Malaria vaccine. He has been involved in launches of many other products across therapeutic categories within the region.
Prior to joining GSK, William worked for the US CDC as a Researcher and at the Gertrude’s Children’s Hospital as a Doctor. He served patients in Kenya’s largest slum as a Doctor and Board of Trustees member for the University of North Carolina’s Carolina for Kibera program.
Anna Walz is a 25+ year veteran in the pharmaceutical industry. She is the Founder and CEO Emeritus of MedEvoke, a MEDISTRAVA Company (Medical Division of Huntsworth). MedEvoke is a global medical consulting firm dedicated to working with Medical Affairs leaders to drive alignment through development of clear medical strategies that can be globally communicated, measured, and analyzed. This has, for the first time, enabled Medial Affairs to track the impact of internal efforts on the external scientific and digital exchanges.
Anna currently serves as Senior Strategic Advisor to MEDISTRAVA and provides professional guidance on the formation of a cross-company Medical Analytics Function that will overlay the community of medical affairs agencies within the healthcare division of Huntsworth. Her external responsibilities include working with key clients and professional organizations on market implementation and validation of the medical analytics function. Internal responsibilities include providing input on annual strategy planning process and relevant roll-out workstreams. Anna also serves of the Board of Directors for Healios AG, a Swiss-based medical device software manufacturer that is dedicated to finding solutions in clinical research and patient monitoring through innovative digital technologies.
Anna, who often speaks on the topics of medical strategy, launch excellence, impact metrics for medical affairs, female entrepreneurship, and diversity in the biosciences, is also a regular guest-lecturer on the topic of Pharmacology & Drug Marketing at the Rutgers Medical School. In addition to speaking, Anna has a keen interest in her own continuing education and is a graduate of both the Tuck-WBENC Executive Education program and the Entrepreneurial Master’s Program (EMP), a joint collaboration of the Entrepreneurs’ Organization (EO) and the Massachusetts Institute of Technology (MIT).
Anna has been one of the most vocal champions for MAPS since its inception, has served as Co-Chair of the Standards & Guidance Committee, and is currently serving on the organization’s Board of Directors and on the Fund Development Committee.
Sherry Siegert, PharmD, is Senior Director of Medical Affairs at La Jolla Pharmaceutical Company. She obtained her B.S. in Biopsychology at the University of California, Santa Barbara, and received her Doctor of Pharmacy from the University of Illinois, Chicago, College of Pharmacy. She was the inaugural pharmacy resident for the Managed Care Specialty Pharmacy Residency program at CVS Caremark-Specialty Pharmacy and has been in the pharmaceutical industry since. With over a decade of experience spanning managed care, commercial and medical affairs, she brings a breadth of experience and perspective to her roles across a variety of therapeutic areas. She has worked at large, medium, and small-sized pharma companies and has led many of the operations within Medical Affairs including but not limited to Medical Information, Investigator Initiated Research, Independent Medical Education, Medical Strategy and Operations. Her passion is continuous improvement through collaboration and innovation within Medical Affairs and showcasing value toward the overall strategy all while helping to improve patient lives.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.